Facts
as of Nov 22, 2026
Bio-Rad Laboratories is a US maker of life science research products and clinical diagnostics. It supplies laboratory instruments, reagents and diagnostic tests to research, clinical and industrial customers worldwide. The company is headquartered in Hercules, California, United States.
- Headquarters
- Hercules, United States
- Founded
- 1952
- Employees
- 3,152+US Form 5500 (plan participants) · Dec 2025 · -6% in a year
- Listing
- NYSE: BIO
These are the key facts about Bio-Rad Laboratories on Alion as of Nov 22, 2026. Bio-Rad Laboratories is headquartered in Hercules, United States. It was founded in 1952.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
4 needs at Bio-Rad Laboratories. Pick what you sell and your market to see which of them are open to you.
Best needs for you
4 needs you can go after are shown to signed-in readers. Sign In
Where Bio-Rad Laboratories is heading
Contract with Univerzita Karlova, Přírodovědecká fakulta ends Jun 2027: "UK 1. LF - Dynamický nákupní systém…Sep 2026 – Jun 2027
Won a public contract: CHU ANGERS, "FOURNITURE DE REACTIFS – AGENTS INFECTIEUX", $2.4M, Sep 2026Sep 2026 – Sep 2027
Won a public contract: UNICANCER ACHATS, "Marché de l'étude d'implantation, la livraison, l'installation, la…Jun 2026 – Jun 2027
Bio-Rad Laboratories returned $295.5M to shareholders in fiscal 2025 and paid $61.6M of income tax.
$61.6MIncome taxes paidFY2025
$295.5MDividends and buybacksFY2025
$157.6MCapital expenditureFY2025
Revenue by yearas filed, with the net income
2025$2.6Bnet income $759.9M
2024$2.6Bnet income −$1.8B
2023$2.7Bnet income −$637.3M
2022$2.8Bnet income −$3.6B
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
Bio-Rad Laboratories operates through 5 legal entities in 4 countries.
Legal entities5 in 4 countries
Bio-Rad Laboratories, Inc.
operator · US EIN 941381833
US
BIO-RAD NORWAY AS
subsidiary
NO
related · LEI 549300ZC1GPV35XYDK53
US
Bio-Rad spol. s r.o.
related
CZ
Holders and shares as each register or filing states them.
People
3,152+EmployeesUS Form 5500 (plan participants) · Dec 2025 · -6% in a year
$141kMedian H-1B wage, 202632 cases
Head countas filed and stated
Where the openings areshare of open roles
AI/ML33%▲
Security33%▼
Operations33%▼
Bio-Rad Laboratories paid US doctors and teaching hospitals $342k in 2025, and $0 for research (CMS Open Payments).
1.6k a monthWikipedia readersBio-Rad Laboratories · -44% y/y
Biggest buyers138 · $19.9M
Centre Universitaire Grenoble Alpes
France · 5 public contracts
$3.3M
UNICANCER ACHATS
France · 1 public contract
$3.2M
CHU ANGERS
France · 1 public contract
$2.4M
Wikipedia readersen.wikipedia.org
Nov 2024Oct 2026 · 1.6k
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Bio-Rad Laboratories: 118 research papers in five years, 689 lb of toxic releases at 1 US sites (EPA TRI, 2024), $320k of EU lobbying in 2025, 34 federal court cases.
Legal entity active
Bio-Rad Laboratories, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Court cases
May 2016 – Aug 2026 · 16 as defendant · 24 closed
34
FDA recalls
27 products since 2012 · 0 of class I
23
US lobbying
2025 · Forbes-Tate $320,000
$320k
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
Source: office addresses in postings and company registers
Tech stack
Technologies named in job postings at Bio-Rad Laboratories over the last 12 months, by layer, with the share of postings for each.
11Technologies in use
2Postings analysed
73/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Newsroom
1.6k a monthWikipedia readersBio-Rad Laboratories · -44% y/y
Sources: the outlets named on each headline, each story once